Kaynaklar :

31. Cal, C. et al. Resveratrol and cancer: chemoprevention, apoptosis, and chemoimmunosensitizing activities. Curr. Med. Chem-Anti-Cancer Agents 2003;3:77-93.

32. Pervaiz, S. Resveratrol-from the bottle to the bedside? Leuk. Lymphoma 2001;40:491-8.

33. Ding, X.Z. et al. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 2002;25:e71-e76.

34. Narayanan, B.A. et al. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci. 2002;70:1821-39.

35. Wolter F, Turchanowa L, Stein J. Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. : Carcinogenesis. 2003 Mar;24(3):469-74.

36. Mahady GB, Pendland SL, Chadwick LR. Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro. 1: Am J Gastroenterol. 2003 Jun;98(6):1440-1.

37. Serrero G, Lu R. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells. Antioxid Redox Signal. 2001 Dec;3(6):969-79.

38. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. 2004 Jun 16;23(12):2369-80. Epub 2004 May 20.

39. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. : Nature. 2004 Jul 14.

40. Verem'eva RE. Means for correcting the microecological disorders of the intestines in children with recurrent bronchitis] Lik Sprava. 1999 Jan-Feb;(1):79-81.

41. Bombardelli E, Morazzoni P. Vitis vinifera L. Fitoterapia 1995;66:291-317.

42. Romeyer F, Macheix J, Sapis J. Changes and importance of oligomeric procyanidins during maturation of grape seeds. Phytochemistry 1986;25:219-221.

43. Bagchi D, Krohn RL, Bagchi M, et al. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997;95:179-189.

44. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-1148.

45. Frankel EN, Kanner J, German JB, et al.Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457.

46. Bombardelli E, Morazzoni P, Carini M, et al.Biological activity of procyanidins from Vitis vinifera L. BioFactors 1997;6:429-431.

47. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317-333.

48. Murray M, Pizzorno J. Procyanidolic oligomers.In: Murray M, Pizzorno J, eds. The Textbook of Natural Medicine. 2nd ed. London: Churchill Livingston; 1999:899-902.

49. Chen ZY, Chan PT, Ho KY, et al. Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups. Chem Phys Lipids 1996;79:157-163.

50. Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther 1998;23:385- 389.

51. Bagchi D, Garg A, Krohn R, et al. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol1998;30:771-776.

52. Robert L, Godeau G, Gavignet-Jeannin C, et al. The effect of procyanidolic oligomers on vascular permeability. A study using quantitative morphology. Pathol Biol (Paris)1990;38:608-616. [Article in French]

53. Hatano T, Yasuhara T, Yoshihara R, et al. Effects of interaction of tannins with coexisting substances. VII. Inhibitory effects of tannins and related polyphenols on xanthine oxidase. Chem Pharm Bull(Tokyo)1990;38:1224-1229.

54. Tebib K, Bessanicon P, Rouanet J. Dietary grape seed tannins affect lipoproteins, lipoproteinlipases, and tissue lipids in rats fed hypercholesterolemic diets. J Nutr 1994;124:2451-2457.

55. Wegrowski J, Robert AM, Moczar M. The effect of procyanidolic oligomers on the composition of normal and hypercholesterolemic rabbit aortas. Biochem Pharmacol 1984;33:3491-3497.

56. Cheshier JE, Ardestani-Kaboudanian S, Liang B, et al. Immunomodulation by pycnogenol in retrovirus-infected or ethanol-fed mice. Life Sci 1996;58:PL 87-96.

57. Liviero L, Puglisi P, Morazzoni P, Bombardelli E. Antimutagenic activity of procyanidins from Vitis vinifera. Fitoterapia 1993;65:203-209.

58. Thebaut JF, Thebaut P, Vin F. Study of Endotelon in functional manifestations of peripheral venous insufficiency. Gaz Med France 1985;92:96-100. [Article in French]

59. Royer RJ, Schmidt CL. Evaluation of venotropic drugs by venous gas plethysmography. A study of procyanidolic oligomers. Sem Hop 1981;57:2009-2013. [Article in French]

60. Pecking A, Desprez-Curely JP, Megret G. OPC (Endotelon) in the treatment of post-therapy lymphedemas of the upper extremities. Int'l d'Antiologie, Toulouse, France, Oct 4-7, 1989;69-73. [Article in French]

« Geri dönmek için tıklayınız.

Sayfa: 1 - 2 - 3